News & Updates

Cholinesterase inhibitors show promise for treating gait disturbance in PD
Cholinesterase inhibitors show promise for treating gait disturbance in PD
07 Dec 2021

Treatment with cholinesterase inhibitors in patients with Parkinson’s disease (PD) leads to significant improvements in gait variability, with trending benefits for gait speed and fall prevention, according to the results of a meta-analysis.

Cholinesterase inhibitors show promise for treating gait disturbance in PD
07 Dec 2021
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021 byAudrey Abella

In children and adolescents with autism spectrum disorder (ASD), intranasal oxytocin did not improve social interaction or other measures of social function related to ASD, the phase II SOARS-B* trial suggests.

Intranasal oxytocin does not enhance social behaviour in children, adolescents with ASD
02 Dec 2021